Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Non-Current Debt: 2021-2022

Historic Non-Current Debt for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2022 value amounting to $109.7 million.

  • ADC Therapeutics' Non-Current Debt rose 1.01% to $97,707 in Q3 2023 from the same period last year, while for Sep 2023 it was $97,707, marking a year-over-year increase of 1.01%. This contributed to the annual value of $109.7 million for FY2022, which is 25.89% up from last year.
  • As of FY2022, ADC Therapeutics' Non-Current Debt stood at $109.7 million, which was up 25.89% from $87.2 million recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Non-Current Debt ranged from a high of $109.7 million in FY2022 and a low of $87.2 million during FY2021.
  • Over the past 2 years, ADC Therapeutics' median Non-Current Debt value was $98.4 million (recorded in 2021), while the average stood at $98.4 million.
  • Data for ADC Therapeutics' Non-Current Debt shows a peak YoY climbed of 25.89% (in 2022) over the last 5 years.
  • Yearly analysis of 2 years shows ADC Therapeutics' Non-Current Debt stood at $87.2 million in 2021, then climbed by 25.89% to $109.7 million in 2022.